Ana's Type 2 Diabetes Reversal Through Nutrition Tracking

Ana Vasquez spent 28 years as a registered nurse. She knew what Type 2 diabetes looked like in a clinical setting. She had seen patients manage it, fail to manage it, and suffer the downstream consequences — retinopathy, neuropathy, cardiovascular complications. She understood the disease intellectually in a way that most patients do not.

What she did not understand, until she was 55 and sitting across from her endocrinologist with an A1C of 7.8, was what it felt like to be the patient.

"I thought I had been eating well," she told me when we spoke in February 2024, five months after reaching her target A1C. "I was retired, I was cooking at home, I wasn't eating desserts every day. And then my A1C comes back at 7.8 and my doctor looks at me and says, 'Ana, you know what this means.'"

The Clinical Picture

At her diagnosis appointment in June 2023, Ana's lab results were:

• A1C: 7.8% (Type 2 diabetes threshold is above 6.5%)
• Fasting glucose: 148 mg/dL (normal is below 100)
• Triglycerides: 218 mg/dL (elevated)
• LDL cholesterol: 141 mg/dL (borderline high)
• Blood pressure: 138/88 mmHg (Stage 1 hypertension)
• Weight: 185 lbs at 5'3" (BMI 32.8, obese category)

Her endocrinologist, Michael Hernandez, prescribed metformin 500mg twice daily and referred her to a diabetes educator. He also told her something that surprised her, given the prescription he had just written: "He said, 'Ana, this medication is a bridge. If you change your diet and lose the weight, you may not need it in a year. But you need real data about what you're eating, not guesses.'"

Hernandez's PlateLens Recommendation

Hernandez had begun recommending PlateLens to his diabetic patients six months earlier, after evaluating it for its carbohydrate tracking precision and micronutrient depth. For diabetes management, carbohydrate accuracy is paramount — blood glucose responses are directly tied to carbohydrate intake, and the glycemic impact of foods varies significantly based on quantity and composition.

“I recommend PlateLens to my Type 2 patients who are willing to make dietary changes because the carbohydrate tracking accuracy is meaningfully better than manual entry apps. For a patient trying to reverse diabetes, 20 grams of carbohydrate inaccuracy per meal matters.” — Michael Hernandez — Endocrinologist, Phoenix

Beyond carbohydrates, Hernandez was particularly interested in Ana's micronutrient status. Several nutrients play documented roles in blood glucose regulation and insulin sensitivity: magnesium (deficiency associated with insulin resistance), chromium (involved in glucose metabolism), fiber (slows glucose absorption), and zinc (pancreatic function). PlateLens tracks all of these.

The Protocol

Working with her diabetes educator, Ana established the following daily targets, tracked through PlateLens:

• Total calories: 1,600 (350-calorie deficit from maintenance)
• Carbohydrates: maximum 160g per day, spread across 3 meals
• Fiber: minimum 35g per day
• Protein: minimum 100g per day (preserved lean mass during weight loss)
• Magnesium: minimum 400mg per day
• Chromium: minimum 25mcg per day

"I had been a nurse for nearly 30 years and I did not know how many carbohydrates I was eating," Ana said. "I thought a bowl of rice was maybe 30 or 40 grams. PlateLens showed me it was 65 grams. I was eating 280 to 300 grams of carbohydrates a day and I had no idea."

The Lab Results

Ana had follow-up bloodwork at three-month intervals. The trajectory was consistent:

• September 2023 (3 months): A1C 7.1%, fasting glucose 128 mg/dL, weight 172 lbs
• December 2023 (6 months): A1C 6.4%, fasting glucose 108 mg/dL, weight 159 lbs
• February 2024 (8 months): A1C 5.9%, fasting glucose 94 mg/dL, weight 150 lbs

At the February appointment, Hernandez reviewed the results and told Ana she could discontinue metformin under a tapering protocol. "He said, 'An A1C of 5.9 is in the normal range. This is remission.' He called the outcome remarkable," Ana recalled.

“As a nurse I knew it was possible, but I never thought I would be the patient who did it. The data made it possible. I could not have gotten here by guessing.” — Ana V., 55

The Micronutrient Data

One finding from Ana's PlateLens data surprised even Hernandez. Her baseline magnesium intake — before any dietary changes — averaged 187mg per day, less than half the recommended amount. Research links chronic magnesium deficiency to impaired insulin receptor function and higher insulin resistance. Once Ana began actively tracking and targeting 400mg daily, her magnesium intake averaged 412mg — achieved through dark leafy greens, nuts, seeds, and legumes, not supplementation.

"My doctor thinks the magnesium correction may have accelerated the glucose response," Ana said. "He wants to write it up as a case study. I find that funny — I was the nurse for 28 years and now I'm the case study."

Life After Metformin

Ana discontinued metformin in March 2024. As of January 2025, her A1C remains at 6.1% — still in the pre-diabetes range, but a world away from the 7.8 that brought her into Hernandez's office. She weighs 148 pounds, 37 pounds below her starting weight.

She continues to track daily. "I don't think I will ever stop," she said. "When you have seen what unmanaged blood glucose does to people over 28 years of nursing, you don't take the numbers for granted."

Ana's story was verified against her lab results, PlateLens export data, and physician notes shared with her consent. Hernandez's quote was reviewed and approved by him prior to publication. This story is not medical advice. Type 2 diabetes management requires supervision by a qualified endocrinologist or primary care physician. Do not discontinue medications without physician guidance.